# SLC25A5

## Overview
SLC25A5 is a gene that encodes the protein adenine nucleotide translocator 2 (ANT2), a member of the solute carrier family 25. This protein is integral to mitochondrial function, specifically facilitating the exchange of ADP and ATP across the inner mitochondrial membrane, which is crucial for cellular energy metabolism. ANT2 is characterized as a transmembrane protein, with a structure comprising six alpha-helices that form a channel for nucleotide transport. It is predominantly expressed in proliferating tissues, including tumors, and plays a significant role in maintaining cellular energy homeostasis. The protein's interactions with various mitochondrial and cellular components underscore its involvement in metabolic regulation and immune response pathways (Gutiérrez-Aguilar2013Physiological; Palmieri2004The; Tripathi2010Network).

## Structure
The SLC25A5 gene encodes a protein that is part of the solute carrier family 25, known for its role in mitochondrial transport. The protein structure is characterized by a tripartite sequence, consisting of three homologous domains, each approximately 100 amino acids in length. These domains contain two hydrophobic stretches that form transmembrane alpha-helices, separated by hydrophilic regions (Palmieri2013The; Palmieri2004The). The protein typically has six transmembrane alpha-helices, arranged in a counter-clockwise order, creating a funnel-shaped cavity open towards the cytosol (Palmieri2013The).

The primary structure of SLC25A5 includes a sequence of amino acids that form the basis for its secondary structure, which is dominated by alpha-helices. The tertiary structure involves the folding of these helices into a stable conformation, essential for its function as a mitochondrial carrier. The quaternary structure often involves the formation of homodimers, with each monomer contributing six transmembrane segments (Palmieri2004The).

Post-translational modifications, such as phosphorylation, may occur, influencing the protein's function and regulation. Splice variants of SLC25A5 can result in different isoforms, potentially affecting its transport capabilities and interactions within the mitochondrial membrane (Palmieri2013The).

## Function
The SLC25A5 gene encodes the adenine nucleotide translocator 2 (ANT2), a protein that plays a crucial role in cellular energy metabolism by facilitating the exchange of ADP and ATP across the inner mitochondrial membrane. This exchange is vital for maintaining the energy balance within cells, as it allows ADP to enter the mitochondria for ATP synthesis and newly synthesized ATP to be exported to the cytosol for cellular activities (Palmieri2004The; Gutiérrez-Aguilar2013Physiological).

ANT2 is primarily expressed in proliferating tissues, such as tumors, and is part of a group of carriers that includes SLC25A4 (ANT1), SLC25A6 (ANT3), and SLC25A31 (ANT4). These carriers are integral to metabolic control and cell fate, as they ensure a continuous supply of ATP to the cytoplasm, which is essential for various cellular processes (Gutiérrez-Aguilar2013Physiological).

In addition to its role in energy metabolism, ANT2 interacts with other mitochondrial components, such as respiratory supercomplexes and the protein import machinery, and binds to type 2 transglutaminase, which helps maintain its ATP/ADP translocating activity. In cardiac tissue, ANT2 also interacts with creatine kinase to facilitate ATP access for creatine phosphate synthesis, highlighting its importance in energy transfer and cellular homeostasis (Gutiérrez-Aguilar2013Physiological).

## Clinical Significance
Mutations and altered expression of the SLC25A5 gene have been implicated in various diseases and conditions. In colon cancer, SLC25A5 is downregulated, and its upregulation is associated with longer overall survival, suggesting its potential as a prognostic marker. High expression of SLC25A5 is linked to better patient outcomes and increased sensitivity to certain chemotherapeutic agents, such as the ROCK inhibitor GSK269962A and foretinib (Chen2022An). The gene's expression is negatively correlated with CD8+ T cell infiltration, indicating a role in modulating immune responses in the tumor microenvironment (Chen2022An).

In the context of genetic disorders, rare damaging variants of SLC25A5 have been identified in a family with hypospadias, suggesting a potential role in the recessive inheritance of this condition (Chen2020Dysregulated). Additionally, mutations in SLC25A5 have been reported in patients with port-wine stains, a congenital capillary malformation, indicating a possible involvement in the pathogenesis of this condition (Chen2022WholeGenome). These findings highlight the clinical significance of SLC25A5 in various pathological states, although further research is needed to fully understand its molecular mechanisms and therapeutic potential.

## Interactions
SLC25A5, also known as adenine nucleotide translocator 2 (ANT2), is involved in various protein interactions that influence cellular processes. It interacts with several proteins related to immune response pathways, including RELA, NFKB1, IKBKG, NFKBIA, TRAF2, and PRKAA1, suggesting its role in pathways such as RIG-I-like receptor signaling, T cell receptor signaling, NOD-like receptor signaling, Toll-like receptor signaling, and Adipocytokine signaling (Tripathi2010Network). These interactions are crucial for both innate and adaptive immunity.

SLC25A5 also interacts with mitochondrial proteins, including subunits of ATP synthase and ATPase enzymes, which may lead to mitochondrial perturbations and a shift towards glycolytic metabolism, a characteristic of cancer cells (Tripathi2010Network). It is implicated in oxidative electron transfer disruptions through interactions with mitochondrial proteins like NDUFS2 and ETFB, contributing to mitochondrial dysfunction and lipid accumulation in hepatocytes (Tripathi2010Network).

In the context of hepatitis C virus (HCV) infection, SLC25A5 interacts with the HCV Core protein, potentially influencing oxidative electron transfer and solute transport (Tripathi2010Network). This interaction may regulate EGFR activity and host energy metabolism, affecting HCV replication and propagation (Tripathi2010Network).


## References


[1. (Chen2020Dysregulated) Zhongzhong Chen, Xiaoling Lin, Yaping Wang, Hua Xie, and Fang Chen. Dysregulated expression of androgen metabolism genes and genetic analysis in hypospadias. Molecular Genetics &amp; Genomic Medicine, June 2020. URL: http://dx.doi.org/10.1002/mgg3.1346, doi:10.1002/mgg3.1346. This article has 10 citations.](https://doi.org/10.1002/mgg3.1346)

[2. (Gutiérrez-Aguilar2013Physiological) Manuel Gutiérrez-Aguilar and Christopher P. Baines. Physiological and pathological roles of mitochondrial slc25 carriers. Biochemical Journal, 454(3):371–386, August 2013. URL: http://dx.doi.org/10.1042/bj20121753, doi:10.1042/bj20121753. This article has 98 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1042/bj20121753)

[3. (Chen2022An) Yan-Jie Chen, Wei-Feng Hong, Meng-Ling Liu, Xi Guo, Yi-Yi Yu, Yue-Hong Cui, Tian-Shu Liu, and Li Liang. An integrated bioinformatic investigation of mitochondrial solute carrier family 25 (slc25) in colon cancer followed by preliminary validation of member 5 (slc25a5) in tumorigenesis. Cell Death &amp; Disease, March 2022. URL: http://dx.doi.org/10.1038/s41419-022-04692-1, doi:10.1038/s41419-022-04692-1. This article has 21 citations.](https://doi.org/10.1038/s41419-022-04692-1)

[4. (Palmieri2013The) Ferdinando Palmieri. The mitochondrial transporter family slc25: identification, properties and physiopathology. Molecular Aspects of Medicine, 34(2–3):465–484, April 2013. URL: http://dx.doi.org/10.1016/j.mam.2012.05.005, doi:10.1016/j.mam.2012.05.005. This article has 612 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.mam.2012.05.005)

[5. (Palmieri2004The) Ferdinando Palmieri. The mitochondrial transporter family (slc25): physiological and pathological implications. Pfl�gers Archiv European Journal of Physiology, 447(5):689–709, February 2004. URL: http://dx.doi.org/10.1007/s00424-003-1099-7, doi:10.1007/s00424-003-1099-7. This article has 624 citations.](https://doi.org/10.1007/s00424-003-1099-7)

[6. (Chen2022WholeGenome) Kai Chen, Yan-Yan Hu, Lin-Lin Wang, Yun Xia, Qian Jiang, Lan Sun, Shan-Shan Qian, Jin-Zhao Wu, Liu-Qing Chen, and Dong-Sheng Li. Whole-genome sequencing identified kcnj12 and slc25a5 mutations in port-wine stains. Frontiers in Medicine, July 2022. URL: http://dx.doi.org/10.3389/fmed.2022.905902, doi:10.3389/fmed.2022.905902. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fmed.2022.905902)

[7. (Tripathi2010Network) Lokesh P. Tripathi, Chikako Kataoka, Shuhei Taguwa, Kohji Moriishi, Yoshio Mori, Yoshiharu Matsuura, and Kenji Mizuguchi. Network based analysis of hepatitis c virus core and ns4b protein interactions. Molecular BioSystems, 6(12):2539, 2010. URL: http://dx.doi.org/10.1039/c0mb00103a, doi:10.1039/c0mb00103a. This article has 42 citations and is from a peer-reviewed journal.](https://doi.org/10.1039/c0mb00103a)